相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The HPV-18 E7 CKII phospho acceptor site is required for maintaining the transformed phenotype of cervical tumour-derived cells
Om Basukala et al.
PLOS PATHOGENS (2019)
Activity of CK2α protein kinase is required for efficient replication of some HPV types
Alla Piirsoo et al.
PLOS PATHOGENS (2019)
The free energy landscape of the oncogene protein E7 of human papillomavirus type 16 reveals a complex interplay between ordered and disordered regions
Predrag Kukic et al.
SCIENTIFIC REPORTS (2019)
Epidemiology and burden of HPV-related disease
Beatriz Serrano et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2018)
Checkpoint Kinase 1 Is Overexpressed during HPV16-Induced Cervical Carcinogenesis
Wei Lin et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2018)
CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation
Silvio E. Perea et al.
SEMINARS IN ONCOLOGY (2018)
Opportunities and challenges for human papillomavirus vaccination in cancer
Richard B. S. Roden et al.
NATURE REVIEWS CANCER (2018)
Monitoring HPV-16 E7 phosphorylation events
Marcela O. Nogueira et al.
VIROLOGY (2017)
A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site
Amira Zine El Abidine et al.
VIROLOGY (2017)
Cancer-type dependent expression of CK2 transcripts
Melissa M. J. Chua et al.
PLOS ONE (2017)
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
Melissa M. J. Chua et al.
PHARMACEUTICALS (2017)
LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models
Darlene Barnard et al.
INVESTIGATIONAL NEW DRUGS (2016)
Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells
Adam J. Rabalski et al.
CLINICAL CANCER RESEARCH (2016)
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
Shih-Hung Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Analysis of Multiple HPV E6 PDZ Interactions Defines Type-Specific PDZ Fingerprints That Predict Oncogenic Potential
Miranda Thomas et al.
PLOS PATHOGENS (2016)
Carcinogenic human papillomavirus infection
Mark Schiffman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Signaling pathways in HPV-associated cancers and therapeutic implications
Jiezhong Chen
REVIEWS IN MEDICAL VIROLOGY (2015)
Cancer-Causing Human Papillomavirus E6 Proteins Display Major Differences in the Phospho-Regulation of Their PDZ Interactions
Siaw Shi Boon et al.
JOURNAL OF VIROLOGY (2015)
Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2α
Jie Liu et al.
MOLECULAR MEDICINE REPORTS (2015)
The Heterogeneous Structural Behavior of E7 from HPV16 Revealed by NMR Spectroscopy
Eduardo O. Calcada et al.
CHEMBIOCHEM (2013)
Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776
Carl G. Engelke et al.
CLINICAL CANCER RESEARCH (2013)
HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers
Joaquin Manzo-Merino et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancersystematic review and meta-analysis of trends by time and region
Hisham Mehanna et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
High-Risk Human Papillomavirus E6 Oncoproteins Interact with 14-3-3ζ in a PDZ Binding Motif-Dependent Manner
Siaw Shi Boon et al.
JOURNAL OF VIROLOGY (2013)
The Role of Protein Kinase A Regulation of the E6 PDZ-Binding Domain during the Differentiation-Dependent Life Cycle of Human Papillomavirus Type 18
Craig P. Delury et al.
JOURNAL OF VIROLOGY (2013)
Preclinical Development of the Novel Chk1 Inhibitor SCH900776 in Combination with DNA-Damaging Agents and Antimetabolites
Ryan Montano et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Global Burden of Human Papillomavirus and Related Diseases
David Forman et al.
VACCINE (2012)
The Biology and Life-Cycle of Human Papillomaviruses
John Doorbar et al.
VACCINE (2012)
Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
Fabrice Pierre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The E7 Open Reading Frame Acts in cis and in trans To Mediate Differentiation-Dependent Activities in the Human Papillomavirus Type 16 Life Cycle
Jason M. Bodily et al.
JOURNAL OF VIROLOGY (2011)
Nonconserved Lysine Residues Attenuate the Biological Function of the Low-Risk Human Papillomavirus E7 Protein
Nicholas J. Genovese et al.
JOURNAL OF VIROLOGY (2011)
Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix
Franca Del Nonno et al.
MODERN PATHOLOGY (2011)
CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
Adam Siddiqui-Jain et al.
CANCER RESEARCH (2010)
14-3-3ζ as a prognostic marker and therapeutic target for cancer
Christopher L. Neal et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7
Lucia B. Chemes et al.
FEBS JOURNAL (2010)
14-3-3 sigma and 14-3-3 zeta plays an opposite role in cell growth inhibition mediated by transforming growth factor-beta 1
Hye-Young Hong et al.
MOLECULES AND CELLS (2010)
Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
Ana M. Solares et al.
BMC CANCER (2009)
The Ubiquitin-Specific Peptidase USP15 Regulates Human Papillomavirus Type 16 E6 Protein Stability
Robin M. Vos et al.
JOURNAL OF VIROLOGY (2009)
The stability of the human papillomavirus E6 oncoprotein is E6AP dependent
Vjekoslav Tomaic et al.
VIROLOGY (2009)
DYRK1A stabilizes HPV16E7 oncoprotein through phosphorylation of the threonine 5 and threonine 7 residues
Yuh-Jin Liang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
USP11 stabilizes HPV-16E7 and further modulates the E7 biological activity
Ching-Hui Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-Phase induction in differentiated human keratinocytes
Nicholas J. Genovese et al.
JOURNAL OF VIROLOGY (2008)
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
Silvio E. Perea et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer
K. Yamato et al.
CANCER GENE THERAPY (2008)
Systemic administration of a peptide that impairs the Protein Kinase (CK2) phosphorylation reduces solid tumor growth in mice
Yasser Perera et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The N-terminal module of HPV16 E7 is an intrinsically disordered domain that confers conformational and recognition plasticity to the oncoprotein
Maria M. Garcia-Alai et al.
BIOCHEMISTRY (2007)
Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: Mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein
Yi Zhang et al.
JOURNAL OF VIROLOGY (2007)
Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7
O. Ohlenschlaeger et al.
ONCOGENE (2006)
Alteration of Rb binding to HPV 18 E7 modified by transglutaminase 2 with different type of polyamines
JH Jeon et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Structural and functional analysis of E6 oncoprotein:: Insights in the molecular pathways of human papillomavirus-mediated pathogenesis
Y Nominé et al.
MOLECULAR CELL (2006)
Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor
X Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Radiosensitization by targeting radioresistance-related genes with protein kinase A inhibitor in radioresistant cancer cells
C Chin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2005)
Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences
M Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins
M Thomas et al.
ONCOGENE (2005)
Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex
S Tugizov et al.
JOURNAL OF VIROLOGY (2005)
SOC1 inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein
M Kamio et al.
ONCOGENE (2004)
2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2
MA Pagano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation
SA Southern et al.
BRITISH JOURNAL OF CANCER (2004)
The tumor suppressor protein p16INK4a and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system -: Direct evidence for ubiquitination at the N-terminal residue
R Ben-Saadon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2)
SE Perea et al.
CANCER RESEARCH (2004)
The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase
KJ Oh et al.
JOURNAL OF VIROLOGY (2004)
Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes
RA Watson et al.
JOURNAL OF CELL SCIENCE (2003)
Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine
JH Jeon et al.
EMBO JOURNAL (2003)
siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells
K Butz et al.
ONCOGENE (2003)
Viruses and the 26S proteasome: hacking into destruction
L Banks et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Transglutaminases: Crosslinking enzymes with pleiotropic functions
L Lorand et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
DW Litchfield
BIOCHEMICAL JOURNAL (2003)
In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA
M Yoshinouchi et al.
MOLECULAR THERAPY (2003)
Cellular steady-state levels of high risk but not low risk human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53-and E6AP-binding capabilities
E Kehmeier et al.
VIROLOGY (2002)
Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins
FA Dick et al.
JOURNAL OF VIROLOGY (2002)
Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells
J Wang et al.
ONCOGENE (2001)
Differential regulation of human papillomavirus E6 by protein kinase A:: conditional degradation of human discs large protein by oncogenic E6
C Kühne et al.
ONCOGENE (2000)
Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue
E Reinstein et al.
ONCOGENE (2000)
Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle
P Massimi et al.
VIROLOGY (2000)
Cyclic nucleotide analogs as biochemical tools and prospective drugs
F Schwede et al.
PHARMACOLOGY & THERAPEUTICS (2000)
Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase
WH Kao et al.
JOURNAL OF VIROLOGY (2000)
PKN binds and phosphorylates human papillomavirus E6 oncoprotein
QS Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The E7 oncoprotein of human papillomavirus type 16 interacts with F-actin in vitro and in vivo
O Rey et al.
VIROLOGY (2000)
分享论文
